Oliver Delgado

Resonant Therapeutics, Inc.

NIH Rank #37744
  • Early Career

NIH Funding · FY2024

Total Funding
$371.1K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#37,744
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $371.1K across 1 grant · National rank #37744.

Top grants by award amount

Oliver Delgado's NIH grant portfolio, ranked by award amount.

  • 1R43CA287873-01A1R43
    Development of a Novel Nectin Targeting Antibody-drug Conjugate for Ovarian Cancer Therapy
    $371.1K
    award amount

Affiliation

Institutions that have administered grants for Oliver Delgado.

Affiliated with Resonant Therapeutics, Inc. (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Resonant Therapeutics, Inc.

Related investigators

Other NIH-funded PIs frequently associated with Oliver Delgado.